Mechanism of Inhibition of Vaccinia Virus Replication in Adenovirus-Infected HeLa Cells
AUTOR(ES)
Giorno, Ralph
RESUMO
The ability of vaccinia virus to replicate in HeLa cells which had been previously infected with adenovirus type 2 (Ad2) was studied in order to gain insight into the mechanism by which adenovirus inhibits the expression of host cell functions. Vaccinia virus was employed in these studies because it replicates in the cytoplasm, whereas Ad2 replicates in the nucleus of the cell. It was found that vaccinia deoxyribonucleic acid (DNA) synthesis is greatly inhibited in adeno-preinfected HeLa cells provided that vaccinia superinfection does not occur before 18 hr after adeno infection. The inhibition of vaccinia DNA synthesis can be traced to an inhibition of vaccinia protein synthesis and viral uncoating. Vaccinia ribonucleic acid (RNA) synthesis is not inhibited in adeno-preinfected cells, but the vaccinia RNA does not become associated with polysomes.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=356100Documentos Relacionados
- In vitro replication of adeno-associated virus DNA: enhancement by extracts from adenovirus-infected HeLa cells.
- Characterization of the SS-B (La) antigen in adenovirus-infected and uninfected HeLa cells.
- Induced heat shock mRNAs escape the nucleocytoplasmic transport block in adenovirus-infected HeLa cells.
- Genomic footprinting detects factors bound to major late and IVa2 promoters in adenovirus-infected HeLa cells.
- Accelerated onset of viral transcription in adenovirus-infected HeLa cells treated with the tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate.
